OpenAI: ChatGPT Displaying Ads for Alcohol, Casinos, Precious Metals Investments, and Other Products Restricted Under Platform’s Ad Policies

Labor Weekly: Midterm Results Pave the Way for States to Repeal Right-to-Work Laws; Dialysis Giants DaVita, Fresenius Accused of Illegal Noncompetes; 10th Circuit’s NCAA Decision Makes It Harder to Argue a Labor Market Is Unique

Welcome to Labor Thursday, our weekly overview of competition and labor market issues. Key stories we’re reporting on this week...

Nov 12, 2026 Read Now >

GOFO: ‘Chinese Controlled’ Last-Mile Deliverer’s Rapid Expansion Relies on Alleged Labor Exploitation

The overnight explosion in the United States of Chinese-controlled last-mile delivery companies such as GOFO Express relies on copycat labor tactics taken from Amazon’s (AMZN) playbook and alleged...

Nov 12, 2026 Read Now >

Health Care Weekly: No Surprises Act Arbiters Dropped for Poor Performance; Hims to Sell Unapproved Wellness Peptides; Telehealth Firm’s GLP-1 Ads Misleading, FDA Says; Novartis Gene Therapies Face Probe over Tumors; Quest Diagnostics Settles Kickback Claims Involving New York Giants NFL Tickets

The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. In this...

Nov 11, 2026 Read Now >

OpenAI: ChatGPT Displaying Ads for Alcohol, Casinos, Precious Metals Investments, and Other Products Restricted Under Platform’s Ad Policies

RELATED ARTICLES | Corporate investigations

Labor Weekly: Midterm Results Pave the Way for States to Repeal Right-to-Work Laws; Dialysis Giants DaVita, Fresenius Accused of Illegal Noncompetes; 10th Circuit’s NCAA Decision Makes It Harder to Argue a Labor Market Is Unique

GOFO: ‘Chinese Controlled’ Last-Mile Deliverer’s Rapid Expansion Relies on Alleged Labor Exploitation

Health Care Weekly: No Surprises Act Arbiters Dropped for Poor Performance; Hims to Sell Unapproved Wellness Peptides; Telehealth Firm’s GLP-1 Ads Misleading, FDA Says; Novartis Gene Therapies Face Probe over Tumors; Quest Diagnostics Settles Kickback Claims Involving New York Giants NFL Tickets

FILTER BY

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.